Biliary tract cancer and genomic alterations in homologous recombinant deficiency: Exploiting synthetic lethality with PARP inhibitors

Research output: Contribution to journalReview article

1 Scopus citations

Fingerprint Dive into the research topics of 'Biliary tract cancer and genomic alterations in homologous recombinant deficiency: Exploiting synthetic lethality with PARP inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences